

Informação sobre produto
Nome:5-Hydroxyisoindoline-1,3-dione
Marca:Biosynth
Descrição:5-Hydroxyisoindoline-1,3-dione is a novel HDAC inhibitor that has been shown to inhibit the activity of human prostate cancer cells. This drug binds to the catalytic site of the HDAC enzyme and prevents acetylation of histones, leading to an increase in transcriptional activity for genes involved in cell proliferation and differentiation. 5-Hydroxyisoindoline-1,3-dione also has a carbonyl group that may be responsible for its selectivity against HDAC2 enzyme. The carbonyl group is thought to interact with the substrate binding site of HDAC2, which would account for its selectivity over other HDAC enzymes. The 5-hydroxyisoindoline moiety is substituted with a hydroxamic acid group that can potentially react with DNA and form a covalent bond. This interaction leads to inhibition of transcriptional activity by preventing acetylation of histones.
Aviso:Os nossos productos estão destinados exclusivamente para uso em laboratório. Para qualquer outra aplicação, por favor entre em contacto.
Propriedades químicas
Peso molecular:163.13 g/mol
Fórmula:C8H5NO3
Pureza:Min. 95%